NEW YORK ( TheStreet) -- CHANGE IN RATINGSAir Products ( APD) upgraded at Argus. APD was upgraded from Hold to Buy. $94 price target. Company should benefit from stronger global economic activity. Celgene ( CELG) upgraded at BofA/Merrill to Buy from Neutral. Valuation call. Price target increased to $70 from $64. CF Industries ( CF) upgraded at UBS from Sell to Neutral. Valuation call, based on $84 price target. Estimates also boosted, because of a better natural gas outlook. Dollar General ( DG) downgraded at MKM from Buy to Neutral. Valuation call, as the stock is up 32% year-to-date. $29 price target. Equifax ( EFX) initiated at BofA/Merrill. EFX coverage initiated at Bank of America/Merrill Lynch with a Neutral rating and $38 price target. Cyclical tailwinds factored in. ITT Educational Services ( ESI) downgraded at Credit Suisse to Neutral from Outperform. Weak guidance and lower-than-expected earnings. Price target sunk to $110 from $135. Fifth Third ( FITB) downgraded at Collins Stewart. FITB was downgraded from Buy to Hold. Valuation call. First Midwest Bancorp ( FMBI) downgraded at Oppenheimer from Outperform to Perform. Valuation call, even though the company delivered strong first quarter results. Hewitt Associates ( HEW) upgraded at Goldman from Sell to Neutral. $41 price target. Estimates also boosted, given higher BPO margins and improving consulting demand. Starwood Hotels ( HOT) upgraded at Stifel from Hold to Buy. Lodging recovery is underway and the company can leverage its real estate platform. $70 price target. Johnson Controls ( JCI) target, estimates boosted at Barclays. JCI price target lifted by a dollar to $36 after 2Q10 beat. 2010 and 2011 EPS estimates raised to $2 and $2.60, respectively. Equal Weight rating. Johnson Controls ( JCI) upgraded at Baird from Neutral to Outperform. $42 price target. Company has strong growth potential in China and should see a rapid recovery in margins. MedAssets ( MDAS) upgraded at Barclays to Overweight from Equal Weight on improving trends in the company's customer base. Price target raised by a dollar to $27. 2010 and 2011 EPS estimates held at $0.77 and $0.95, respectively. Newell Rubbermaid ( NWL) downgraded at BMO from Outperform to Market Perform. Valuation call, based on a $17 price target.
Prosperity Bancshares ( PRSP) downgraded at Suntrust from Outperform to Market Perform. Valuation call, even though the company had a solid first quarter. SPX Corp ( SPW) upgraded at BofA/Merrill to Buy from Neutral as the industrial economy has entered an expansion phase that can be sustained. Price target surged to $87 from $58. Sysco ( SYY) upgraded at UBS. SYY was upgraded from Neutral to Buy. $37 price target. Estimates also raised, because of improving restaurant trends. Thermo Fisher ( TMO) upgraded at Jefferies from Hold to Buy. $62 price target. Company should benefit from industrial recovery. Trustmark ( TRMK) downgraded at KBW from Outperform to Market Perform. Valuation call, based on a $28 price target. Total System Services ( TSS) initiated at BofA/Merrill with an Underperform rating and $16 price target. Persistent headwinds. EPS growth could resume in 2011. VMWare ( VMW) rated new Buy at MKM Partners. $80 price target. Company should deliver significant free cash flow growth over the next two years. Zimmer Holdings ( ZMH) upgraded at JP Morgan. Rating raised to Overweight from Neutral. Price target raised to $70 from $68. Maintains 2010 EPS estimates of $4.27.
STOCK COMMENTS / EPS CHANGESA123 Systems ( AONE) price target trimmed at Barclays to $17 from $18 on concerns over Chrysler relationship. AONE could likely receive DOE funding soon. Equal Weight rating. American Express ( AXP) numbers boosted at Goldman. Shares of AXP now seen reaching $50. Estimates also upped, because of improving credit and cost trends. Neutral rating. Beckman Coulter ( BEC) estimates cut at Morgan Stanley through 2012. Troponin should weigh on earnings and the company is spending more on quality control. Equal-weight rating. Boston Scientific ( BSX) estimates boosted at UBS through 2011. Company should see sales recover, with the sales halt removed. Buy rating and $8 price target. Bucyrus ( BUCY) estimates, target boosted at Morgan Stanley. BUCY estimates were upped through 2011. Channel checks suggest better mining results. Overweight rating and new $80 price target. Cardinal Health ( CAH) numbers upped at UBS. CAH estimates were boosted through 2011. Company should benefit from a strong generic drug pipeline. Buy rating and new $43 price target.
Cisco Systems ( CSCO) numbers raised at Oppenheimer. Shares of CSCO now seen reaching $32. Estimates also increased, following positive channel checks. Outperform rating. Dollar General ( DG) price target boosted at BofA/Merrill. DG price target raised to $36 from $30 on consistent execution and growth prospects. Reiterate Buy rating. Dover ( DOV) estimates, target upped at Morgan Stanley. Shares of DOV now seen reaching $63. Company is seeing higher order trends and deserves a higher multiple. Overweight rating. Corning ( GLW) estimates raised at Goldman. GLW estimates were increased through 2012. Inventory remains tight in the LCD supply chain. Buy rating. Hudson City Bancorp ( HCBK) numbers lowered at FBR. HCBK estimates were cut through 2011. Company is seeing slower balance sheet growth. Outperform rating and new $15 price target. Honeywell ( HON) estimates, target raised at UBS. Shares of HON now seen reaching $47. Estimates also increased, given better end-market demand and M&A opportunities. Neutral rating. Ingersoll-Rand ( IR) numbers raised at Morgan Stanley. Shares of IR now seen reaching $38. Estimates also increased, given stronger orders. Equal-weight rating. Massey Energy ( MEE) numbers lowered at Goldman. Estimates were cut through 2012. Company will likely faces rising costs. Neutral rating and new $50 price target. Nike ( NKE) estimates, target increased at Goldman. NKE estimates were raised through 2012. Company likely to talk up accelerating growth trends at its upcoming investor meeting. Buy rating and new $85 price target. O'Reilly Automotive ( ORLY) price target raised at BofA/Merrill. ORLY price target lifted to $52 from $46 as 1Q10 is expected to benefit from early spring and DC progress. Maintain Buy rating. Patriot Coal ( PCX) numbers boosted at Goldman. Shares of PCX now seen reaching $25. Estimates also upped, given the company's new production guidance and lower expected costs. Sell rating. Raytheon ( RTN) estimates, target upped at Goldman. RTN estimates were boosted through 2012. Company will likely repurchase more shares. Neutral rating and new $52 price target. Schlumberger ( SLB) target, estimates boosted at Citi. SLB price target jumped to $92 from $84 as the international recovery is ahead of expectations. 2010 and 2011 EPS estimates lifted to $2.95 and $3.65, respectively. Maintain Buy rating.
Verizon Communications ( VZ) target, estimates cut at Barclays. VZ price target lowered a dollar to $32 on expected lower wireline margins. 2010 and 2011 EPS estimates sunk to $2.14 and $2.31, respectively. Maintain Equal Weight rating. Webster Financial ( WBS) numbers increased at FBR. Shares of WBS now seen reaching $18. Estimates also raised, given lower credit costs. Market Perform rating. Wesco ( WCC) estimates, target increased at UBS. Shares of WCC now seen reaching $47. Estimates also raised, as the company is seeing higher industrial sales and is paying down debt. Buy rating.